It is intended for use in conjunction with a reduced-calorie diet and increased physical activity, forming a comprehensive approach to weight management
For patients with specific drug combination questions Patients on other medications should understand potential interactions
Socioeconomic context, patient values, expectations, and personal goals must also be considered." Although still relatively recently approved for obesity treatment, the evidence base for both semaglutide (a glucagon-like peptide-1 [GLP-1] receptor agonist) and tirzepatide (a dual gastric inhibitory polypeptide [GIP] and GLP-1 receptor agonist) has been building rapidly
Thus, a total of 38 articles met the inclusion criteria and were included in the final analysis (Fig
If blood work is also being drawn, following any fasting instructions from your healthcare provider takes priority over these recommendations
This is very rare, but there is a phenomenon with these medications that can change how you appreciate smells and tastes, he told me